Literature DB >> 12171965

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

K R Neal1, L Barker, R C Spiller.   

Abstract

BACKGROUND: Irritable bowel syndrome developing following infective gastroenteritis accounts for approximately 1 in 10 of unselected IBS patients. AIMS: To define the long term natural history of post-infective IBS (PI-IBS).
METHODS: A total of 436 individuals, who had previously responded to a questionnaire on their bowel habits following an acute episode of gastroenteritis, were sent a questionnaire about their current bowel habits and physical and mental health six years after their initial illness.
RESULTS: Complete data on original bowel habit, episodes of gastroenteritis, mental health history, and subsequent bowel habit at six years were obtained in 192 individuals. Of these, there were 14 cases of "post-infective IBS" (PI-IBS) and 13 who had IBS prior to infection (previous IBS). Over the six year follow up period there were 20 "new non-infective IBS cases" (new IBS). The strongest risk factor for developing any type of IBS was female sex (relative risk 2.2, p<0.05). Compared with new IBS, those with PI-IBS had significantly more days with loose stools (p<0.05) but a similar number of days with pain, urgency, and bloating. Six of 14 (43%) PI-IBS and four of 13 (31%) previous IBS patients recovered by six years (NS). Of 27 IBS patients followed for six years, only 1/8 with a history of anxiety or depression recovered compared with 9/19 without such a history (p=0.19).
CONCLUSION: PI-IBS differs from non-infective IBS by having more diarrhoeal features. Less than half of both PI-IBS and non-infective IBS cases recover over six years. A history of anxiety and depression severe enough to warrant treatment may impair recovery but larger numbers are needed to prove this.

Entities:  

Mesh:

Year:  2002        PMID: 12171965      PMCID: PMC1773359          DOI: 10.1136/gut.51.3.410

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study.

Authors:  L A Rodríguez; A Ruigómez
Journal:  BMJ       Date:  1999-02-27

Review 2.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

3.  Irritable bowel syndrome--post salmonella infection.

Authors:  M W McKendrick; N W Read
Journal:  J Infect       Date:  1994-07       Impact factor: 6.072

4.  Level of chronic life stress predicts clinical outcome in irritable bowel syndrome.

Authors:  E J Bennett; C C Tennant; C Piesse; C A Badcock; J E Kellow
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

5.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

6.  Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients.

Authors:  K R Neal; J Hebden; R Spiller
Journal:  BMJ       Date:  1997-03-15

7.  Irritable bowel syndrome in general practice: prevalence, characteristics, and referral.

Authors:  W G Thompson; K W Heaton; G T Smyth; C Smyth
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

8.  The role of psychological and biological factors in postinfective gut dysfunction.

Authors:  K A Gwee; Y L Leong; C Graham; M W McKendrick; S M Collins; S J Walters; J E Underwood; N W Read
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

9.  Urgency and fecal soiling in people with bowel dysfunction.

Authors:  D A Drossman; R S Sandler; C M Broom; D C McKee
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

Review 10.  Clinical economics review: irritable bowel syndrome.

Authors:  N E Wells; B A Hahn; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1997-12       Impact factor: 8.171

  10 in total
  65 in total

1.  Infection and irritability.

Authors:  R Lea; P J Whorwell
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

2.  East meets West: infection, nerves, and mast cells in the irritable bowel syndrome.

Authors:  S M Collins; G Barbara
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

3.  Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora?

Authors:  Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

4.  The 2005 Annual Meeting of the British Society of Gastroenterology. Birmingham, United Kingdom, 14-17 March 2005. Abstracts.

Authors: 
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

5.  Transient neonatal Cryptosporidium parvum infection triggers long-term jejunal hypersensitivity to distension in immunocompetent rats.

Authors:  Rachel Marion; Asiya Baishanbo; Gilles Gargala; Arnaud François; Philippe Ducrotté; Celia Duclos; Jean Fioramonti; Jean Jacques Ballet; Loïc Favennec
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Irritable Bowel Syndrome: Bacterial Overgrowth--What's Known and What to Do.

Authors:  Mark Pimentel; Sheila Lezcano
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

Review 7.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

Review 8.  Post-infectious irritable bowel syndrome.

Authors:  Andrew W Dupont
Journal:  Curr Gastroenterol Rep       Date:  2007-10

9.  Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions.

Authors:  Gabrio Bassotti; Giuseppe de Roberto; Fabio Chistolini; Francis Sietchiping-Nzepa; Olivia Morelli; Antonio Morelli
Journal:  Int J Colorectal Dis       Date:  2004-04-09       Impact factor: 2.571

10.  Chronic diarrhea in travelers.

Authors:  Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.